nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PTGS2—bone cancer	0.176	1	CbGaD
Indomethacin—ABCC11—Methotrexate—bone cancer	0.0819	0.13	CbGbCtD
Indomethacin—ABCC6—Cisplatin—bone cancer	0.0724	0.115	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—bone cancer	0.0646	0.102	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—bone cancer	0.0485	0.0769	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—bone cancer	0.0379	0.0601	CbGbCtD
Indomethacin—ABCC3—Cisplatin—bone cancer	0.0348	0.0551	CbGbCtD
Indomethacin—ABCC1—Epirubicin—bone cancer	0.0269	0.0427	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—bone cancer	0.0233	0.0369	CbGbCtD
Indomethacin—ABCC3—Methotrexate—bone cancer	0.0226	0.0358	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—bone cancer	0.0185	0.0294	CbGbCtD
Indomethacin—ABCC2—Carboplatin—bone cancer	0.0185	0.0293	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—bone cancer	0.0177	0.028	CbGbCtD
Indomethacin—ABCC4—Methotrexate—bone cancer	0.0173	0.0273	CbGbCtD
Indomethacin—ABCC2—Cisplatin—bone cancer	0.0158	0.025	CbGbCtD
Indomethacin—PTGS2—Cisplatin—bone cancer	0.0156	0.0248	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—bone cancer	0.0143	0.0227	CbGbCtD
Indomethacin—ABCC1—Methotrexate—bone cancer	0.0139	0.022	CbGbCtD
Indomethacin—SLCO1A2—Methotrexate—bone cancer	0.0124	0.0196	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—bone cancer	0.0117	0.0185	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—bone cancer	0.0108	0.0171	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—bone cancer	0.0106	0.0168	CbGbCtD
Indomethacin—ABCC2—Methotrexate—bone cancer	0.0103	0.0163	CbGbCtD
Indomethacin—SLC22A6—Methotrexate—bone cancer	0.00751	0.0119	CbGbCtD
Indomethacin—ALB—Methotrexate—bone cancer	0.0064	0.0101	CbGbCtD
Indomethacin—CYP2C9—Cisplatin—bone cancer	0.00531	0.00841	CbGbCtD
Indomethacin—ABCB1—Cisplatin—bone cancer	0.00516	0.00817	CbGbCtD
Indomethacin—ABCB1—Doxorubicin—bone cancer	0.00346	0.00547	CbGbCtD
Indomethacin—ABCB1—Methotrexate—bone cancer	0.00335	0.0053	CbGbCtD
Indomethacin—PPARG—periosteum—bone cancer	0.00153	0.0838	CbGeAlD
Indomethacin—PPARG—leg—bone cancer	0.00122	0.0668	CbGeAlD
Indomethacin—PPARG—forelimb—bone cancer	0.00121	0.0663	CbGeAlD
Indomethacin—PPARG—hindlimb—bone cancer	0.00109	0.0596	CbGeAlD
Indomethacin—PTGDR2—tendon—bone cancer	0.000939	0.0512	CbGeAlD
Indomethacin—PPARG—appendage—bone cancer	0.000937	0.0512	CbGeAlD
Indomethacin—Fenofibrate—CYP3A4—bone cancer	0.000813	0.289	CrCbGaD
Indomethacin—PTGS2—periosteum—bone cancer	0.000784	0.0428	CbGeAlD
Indomethacin—Bromfenac—PTGS2—bone cancer	0.000728	0.259	CrCbGaD
Indomethacin—PTGS2—leg—bone cancer	0.000625	0.0341	CbGeAlD
Indomethacin—PTGR2—tendon—bone cancer	0.000623	0.034	CbGeAlD
Indomethacin—PTGR2—spinal cord—bone cancer	0.000601	0.0328	CbGeAlD
Indomethacin—PTGS2—hindlimb—bone cancer	0.000558	0.0305	CbGeAlD
Indomethacin—PTGS2—cartilage tissue—bone cancer	0.00055	0.03	CbGeAlD
Indomethacin—PLA2G2A—connective tissue—bone cancer	0.000521	0.0284	CbGeAlD
Indomethacin—ABCC6—connective tissue—bone cancer	0.000516	0.0281	CbGeAlD
Indomethacin—Tolmetin—PTGS2—bone cancer	0.000489	0.174	CrCbGaD
Indomethacin—PPARA—connective tissue—bone cancer	0.000487	0.0265	CbGeAlD
Indomethacin—PTGS2—appendage—bone cancer	0.000479	0.0261	CbGeAlD
Indomethacin—Bezafibrate—CYP3A4—bone cancer	0.000411	0.146	CrCbGaD
Indomethacin—GLO1—tendon—bone cancer	0.000385	0.021	CbGeAlD
Indomethacin—GLO1—bone marrow—bone cancer	0.000373	0.0204	CbGeAlD
Indomethacin—GLO1—spinal cord—bone cancer	0.000371	0.0203	CbGeAlD
Indomethacin—Naproxen—PTGS2—bone cancer	0.000368	0.131	CrCbGaD
Indomethacin—CES1—connective tissue—bone cancer	0.000361	0.0197	CbGeAlD
Indomethacin—PLA2G2A—tendon—bone cancer	0.000358	0.0195	CbGeAlD
Indomethacin—CXCL8—bone marrow—bone cancer	0.000343	0.0187	CbGeAlD
Indomethacin—CXCL8—spinal cord—bone cancer	0.000342	0.0187	CbGeAlD
Indomethacin—AKR1C3—tendon—bone cancer	0.000278	0.0152	CbGeAlD
Indomethacin—AKR1C3—bone marrow—bone cancer	0.000269	0.0147	CbGeAlD
Indomethacin—AKR1C3—spinal cord—bone cancer	0.000268	0.0146	CbGeAlD
Indomethacin—PPARG—connective tissue—bone cancer	0.000268	0.0146	CbGeAlD
Indomethacin—PPARG—tendon—bone cancer	0.000184	0.01	CbGeAlD
Indomethacin—Anxiety—Cisplatin—bone cancer	0.000182	0.00208	CcSEcCtD
Indomethacin—Hot flush—Doxorubicin—bone cancer	0.000181	0.00206	CcSEcCtD
Indomethacin—Discomfort—Cisplatin—bone cancer	0.000181	0.00206	CcSEcCtD
Indomethacin—Menopausal symptoms—Doxorubicin—bone cancer	0.00018	0.00205	CcSEcCtD
Indomethacin—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00018	0.00205	CcSEcCtD
Indomethacin—Renal impairment—Doxorubicin—bone cancer	0.000178	0.00203	CcSEcCtD
Indomethacin—PPARG—bone marrow—bone cancer	0.000178	0.00972	CbGeAlD
Indomethacin—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000176	0.00201	CcSEcCtD
Indomethacin—Purpura—Doxorubicin—bone cancer	0.000176	0.002	CcSEcCtD
Indomethacin—Oedema—Cisplatin—bone cancer	0.000175	0.002	CcSEcCtD
Indomethacin—Anaphylactic shock—Cisplatin—bone cancer	0.000175	0.002	CcSEcCtD
Indomethacin—Hypoglycaemia—Doxorubicin—bone cancer	0.000174	0.00198	CcSEcCtD
Indomethacin—Thrombocytopenia—Cisplatin—bone cancer	0.000172	0.00196	CcSEcCtD
Indomethacin—Tachycardia—Cisplatin—bone cancer	0.000171	0.00195	CcSEcCtD
Indomethacin—Hyponatraemia—Doxorubicin—bone cancer	0.00017	0.00194	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00017	0.00193	CcSEcCtD
Indomethacin—Diplopia—Doxorubicin—bone cancer	0.00017	0.00193	CcSEcCtD
Indomethacin—Osteoarthritis—Doxorubicin—bone cancer	0.00017	0.00193	CcSEcCtD
Indomethacin—Hyperhidrosis—Cisplatin—bone cancer	0.00017	0.00193	CcSEcCtD
Indomethacin—Asthma—Methotrexate—bone cancer	0.000169	0.00193	CcSEcCtD
Indomethacin—Abdominal pain upper—Epirubicin—bone cancer	0.000167	0.00191	CcSEcCtD
Indomethacin—SLCO1A2—spinal cord—bone cancer	0.000167	0.00913	CbGeAlD
Indomethacin—Anorexia—Cisplatin—bone cancer	0.000167	0.0019	CcSEcCtD
Indomethacin—ABCC4—tendon—bone cancer	0.000167	0.00911	CbGeAlD
Indomethacin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000165	0.00188	CcSEcCtD
Indomethacin—Hypotension—Cisplatin—bone cancer	0.000164	0.00187	CcSEcCtD
Indomethacin—Abdominal discomfort—Methotrexate—bone cancer	0.000162	0.00185	CcSEcCtD
Indomethacin—Gastritis—Epirubicin—bone cancer	0.000162	0.00185	CcSEcCtD
Indomethacin—ABCC4—bone marrow—bone cancer	0.000162	0.00883	CbGeAlD
Indomethacin—Muscular weakness—Epirubicin—bone cancer	0.000162	0.00184	CcSEcCtD
Indomethacin—ABCC2—tendon—bone cancer	0.000162	0.00882	CbGeAlD
Indomethacin—Pancytopenia—Methotrexate—bone cancer	0.000161	0.00183	CcSEcCtD
Indomethacin—Abdominal distension—Epirubicin—bone cancer	0.000159	0.00182	CcSEcCtD
Indomethacin—Asthma—Epirubicin—bone cancer	0.000158	0.0018	CcSEcCtD
Indomethacin—Paraesthesia—Cisplatin—bone cancer	0.000158	0.00179	CcSEcCtD
Indomethacin—Dyspnoea—Cisplatin—bone cancer	0.000156	0.00178	CcSEcCtD
Indomethacin—Abdominal pain upper—Doxorubicin—bone cancer	0.000155	0.00176	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000153	0.00174	CcSEcCtD
Indomethacin—Decreased appetite—Cisplatin—bone cancer	0.000153	0.00174	CcSEcCtD
Indomethacin—Drowsiness—Methotrexate—bone cancer	0.000151	0.00172	CcSEcCtD
Indomethacin—Depression—Methotrexate—bone cancer	0.000151	0.00171	CcSEcCtD
Indomethacin—Pancytopenia—Epirubicin—bone cancer	0.00015	0.00171	CcSEcCtD
Indomethacin—Gastritis—Doxorubicin—bone cancer	0.00015	0.00171	CcSEcCtD
Indomethacin—Pain—Cisplatin—bone cancer	0.00015	0.00171	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00015	0.0017	CcSEcCtD
Indomethacin—Muscular weakness—Doxorubicin—bone cancer	0.00015	0.0017	CcSEcCtD
Indomethacin—Renal failure—Methotrexate—bone cancer	0.000148	0.00169	CcSEcCtD
Indomethacin—Abdominal distension—Doxorubicin—bone cancer	0.000148	0.00168	CcSEcCtD
Indomethacin—Stomatitis—Methotrexate—bone cancer	0.000147	0.00167	CcSEcCtD
Indomethacin—Asthma—Doxorubicin—bone cancer	0.000147	0.00167	CcSEcCtD
Indomethacin—Pollakiuria—Epirubicin—bone cancer	0.000146	0.00167	CcSEcCtD
Indomethacin—Sweating—Methotrexate—bone cancer	0.000145	0.00165	CcSEcCtD
Indomethacin—Feeling abnormal—Cisplatin—bone cancer	0.000145	0.00165	CcSEcCtD
Indomethacin—Weight increased—Epirubicin—bone cancer	0.000144	0.00164	CcSEcCtD
Indomethacin—Haematuria—Methotrexate—bone cancer	0.000144	0.00164	CcSEcCtD
Indomethacin—PTGS1—connective tissue—bone cancer	0.000143	0.0078	CbGeAlD
Indomethacin—Hyperglycaemia—Epirubicin—bone cancer	0.000143	0.00163	CcSEcCtD
Indomethacin—ABCC1—tendon—bone cancer	0.000142	0.00777	CbGeAlD
Indomethacin—Epistaxis—Methotrexate—bone cancer	0.000142	0.00162	CcSEcCtD
Indomethacin—Drowsiness—Epirubicin—bone cancer	0.000141	0.00161	CcSEcCtD
Indomethacin—Agranulocytosis—Methotrexate—bone cancer	0.000141	0.0016	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00014	0.00159	CcSEcCtD
Indomethacin—Pancytopenia—Doxorubicin—bone cancer	0.000139	0.00158	CcSEcCtD
Indomethacin—Renal failure—Epirubicin—bone cancer	0.000139	0.00158	CcSEcCtD
Indomethacin—Body temperature increased—Cisplatin—bone cancer	0.000139	0.00158	CcSEcCtD
Indomethacin—Neuropathy peripheral—Epirubicin—bone cancer	0.000138	0.00158	CcSEcCtD
Indomethacin—Stomatitis—Epirubicin—bone cancer	0.000138	0.00157	CcSEcCtD
Indomethacin—Jaundice—Epirubicin—bone cancer	0.000138	0.00157	CcSEcCtD
Indomethacin—PTGS2—connective tissue—bone cancer	0.000137	0.00746	CbGeAlD
Indomethacin—Haemoglobin—Methotrexate—bone cancer	0.000136	0.00155	CcSEcCtD
Indomethacin—Hepatitis—Methotrexate—bone cancer	0.000136	0.00154	CcSEcCtD
Indomethacin—Haemorrhage—Methotrexate—bone cancer	0.000136	0.00154	CcSEcCtD
Indomethacin—Sweating—Epirubicin—bone cancer	0.000135	0.00154	CcSEcCtD
Indomethacin—Pollakiuria—Doxorubicin—bone cancer	0.000135	0.00154	CcSEcCtD
Indomethacin—Haematuria—Epirubicin—bone cancer	0.000135	0.00153	CcSEcCtD
Indomethacin—Weight increased—Doxorubicin—bone cancer	0.000133	0.00152	CcSEcCtD
Indomethacin—Epistaxis—Epirubicin—bone cancer	0.000133	0.00152	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—bone cancer	0.000132	0.00151	CcSEcCtD
Indomethacin—Agranulocytosis—Epirubicin—bone cancer	0.000132	0.0015	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—bone cancer	0.000131	0.00149	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00013	0.00147	CcSEcCtD
Indomethacin—Hypersensitivity—Cisplatin—bone cancer	0.000129	0.00147	CcSEcCtD
Indomethacin—Bradycardia—Epirubicin—bone cancer	0.000129	0.00147	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—bone cancer	0.000128	0.00146	CcSEcCtD
Indomethacin—Erythema multiforme—Methotrexate—bone cancer	0.000128	0.00146	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—bone cancer	0.000128	0.00146	CcSEcCtD
Indomethacin—Haemoglobin—Epirubicin—bone cancer	0.000127	0.00145	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—bone cancer	0.000127	0.00145	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—bone cancer	0.000127	0.00145	CcSEcCtD
Indomethacin—Hepatitis—Epirubicin—bone cancer	0.000127	0.00144	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—bone cancer	0.000127	0.00144	CcSEcCtD
Indomethacin—Tinnitus—Methotrexate—bone cancer	0.000126	0.00144	CcSEcCtD
Indomethacin—Asthenia—Cisplatin—bone cancer	0.000126	0.00143	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—bone cancer	0.000125	0.00143	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—bone cancer	0.000125	0.00142	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—bone cancer	0.000123	0.0014	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—bone cancer	0.000122	0.00139	CcSEcCtD
Indomethacin—Diarrhoea—Cisplatin—bone cancer	0.00012	0.00137	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—bone cancer	0.00012	0.00136	CcSEcCtD
Indomethacin—Alopecia—Methotrexate—bone cancer	0.00012	0.00136	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—bone cancer	0.000119	0.00136	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—bone cancer	0.000118	0.00135	CcSEcCtD
Indomethacin—Erythema—Methotrexate—bone cancer	0.000118	0.00134	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—bone cancer	0.000118	0.00134	CcSEcCtD
Indomethacin—Flushing—Epirubicin—bone cancer	0.000118	0.00134	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—bone cancer	0.000117	0.00134	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—bone cancer	0.000117	0.00134	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—bone cancer	0.000113	0.00129	CcSEcCtD
Indomethacin—Alopecia—Epirubicin—bone cancer	0.000112	0.00128	CcSEcCtD
Indomethacin—Vomiting—Cisplatin—bone cancer	0.000112	0.00127	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—bone cancer	0.000111	0.00127	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—bone cancer	0.000111	0.00126	CcSEcCtD
Indomethacin—Rash—Cisplatin—bone cancer	0.000111	0.00126	CcSEcCtD
Indomethacin—Dermatitis—Cisplatin—bone cancer	0.000111	0.00126	CcSEcCtD
Indomethacin—Erythema—Epirubicin—bone cancer	0.00011	0.00126	CcSEcCtD
Indomethacin—Ill-defined disorder—Methotrexate—bone cancer	0.000109	0.00125	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—bone cancer	0.000109	0.00125	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—bone cancer	0.000109	0.00124	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—bone cancer	0.000109	0.00124	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—bone cancer	0.000109	0.00124	CcSEcCtD
Indomethacin—Tension—Epirubicin—bone cancer	0.000108	0.00123	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—bone cancer	0.000107	0.00122	CcSEcCtD
Indomethacin—Malaise—Methotrexate—bone cancer	0.000106	0.00121	CcSEcCtD
Indomethacin—Vertigo—Methotrexate—bone cancer	0.000106	0.00121	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—bone cancer	0.000106	0.0012	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—bone cancer	0.000105	0.00119	CcSEcCtD
Indomethacin—Nausea—Cisplatin—bone cancer	0.000104	0.00119	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—bone cancer	0.000104	0.00118	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—bone cancer	0.000104	0.00118	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—bone cancer	0.000102	0.00117	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—bone cancer	0.000102	0.00116	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—bone cancer	0.000102	0.00116	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—bone cancer	0.000102	0.00116	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—bone cancer	0.000101	0.00115	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—bone cancer	0.0001	0.00114	CcSEcCtD
Indomethacin—Tension—Doxorubicin—bone cancer	0.0001	0.00114	CcSEcCtD
Indomethacin—Malaise—Epirubicin—bone cancer	9.96e-05	0.00113	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—bone cancer	9.92e-05	0.00113	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—bone cancer	9.92e-05	0.00113	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—bone cancer	9.92e-05	0.00113	CcSEcCtD
Indomethacin—Syncope—Epirubicin—bone cancer	9.9e-05	0.00113	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—bone cancer	9.88e-05	0.00112	CcSEcCtD
Indomethacin—PTGS1—tendon—bone cancer	9.83e-05	0.00536	CbGeAlD
Indomethacin—Palpitations—Epirubicin—bone cancer	9.76e-05	0.00111	CcSEcCtD
Indomethacin—Confusional state—Methotrexate—bone cancer	9.71e-05	0.0011	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—bone cancer	9.7e-05	0.0011	CcSEcCtD
Indomethacin—Anaphylactic shock—Methotrexate—bone cancer	9.63e-05	0.0011	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—bone cancer	9.63e-05	0.0011	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—bone cancer	9.56e-05	0.00109	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—bone cancer	9.53e-05	0.00108	CcSEcCtD
Indomethacin—PTGS1—spinal cord—bone cancer	9.48e-05	0.00517	CbGeAlD
Indomethacin—Ill-defined disorder—Doxorubicin—bone cancer	9.48e-05	0.00108	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—bone cancer	9.44e-05	0.00107	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—bone cancer	9.43e-05	0.00107	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—bone cancer	9.4e-05	0.00107	CcSEcCtD
Indomethacin—PTGS2—tendon—bone cancer	9.4e-05	0.00513	CbGeAlD
Indomethacin—Anxiety—Epirubicin—bone cancer	9.37e-05	0.00107	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—bone cancer	9.31e-05	0.00106	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—bone cancer	9.29e-05	0.00106	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—bone cancer	9.21e-05	0.00105	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—bone cancer	9.18e-05	0.00104	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—bone cancer	9.18e-05	0.00104	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—bone cancer	9.16e-05	0.00104	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—bone cancer	9.14e-05	0.00104	CcSEcCtD
Indomethacin—PTGS2—bone marrow—bone cancer	9.1e-05	0.00497	CbGeAlD
Indomethacin—Confusional state—Epirubicin—bone cancer	9.08e-05	0.00103	CcSEcCtD
Indomethacin—PTGS2—spinal cord—bone cancer	9.06e-05	0.00495	CbGeAlD
Indomethacin—Palpitations—Doxorubicin—bone cancer	9.03e-05	0.00103	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—bone cancer	9.01e-05	0.00103	CcSEcCtD
Indomethacin—Oedema—Epirubicin—bone cancer	9.01e-05	0.00103	CcSEcCtD
Indomethacin—Hypotension—Methotrexate—bone cancer	9e-05	0.00102	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—bone cancer	8.98e-05	0.00102	CcSEcCtD
Indomethacin—Shock—Epirubicin—bone cancer	8.86e-05	0.00101	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—bone cancer	8.85e-05	0.00101	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—bone cancer	8.82e-05	0.001	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—bone cancer	8.82e-05	0.001	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—bone cancer	8.79e-05	0.001	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—bone cancer	8.71e-05	0.000991	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—bone cancer	8.71e-05	0.000991	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—bone cancer	8.7e-05	0.00099	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—bone cancer	8.67e-05	0.000986	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—bone cancer	8.64e-05	0.000984	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—bone cancer	8.59e-05	0.000978	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—bone cancer	8.59e-05	0.000977	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—bone cancer	8.58e-05	0.000977	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—bone cancer	8.56e-05	0.000974	CcSEcCtD
Indomethacin—Dyspepsia—Methotrexate—bone cancer	8.47e-05	0.000965	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—bone cancer	8.42e-05	0.000958	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—bone cancer	8.41e-05	0.000957	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—bone cancer	8.37e-05	0.000953	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—bone cancer	8.34e-05	0.000949	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—bone cancer	8.34e-05	0.000949	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—bone cancer	8.3e-05	0.000945	CcSEcCtD
Indomethacin—Pain—Methotrexate—bone cancer	8.23e-05	0.000937	CcSEcCtD
Indomethacin—Shock—Doxorubicin—bone cancer	8.2e-05	0.000934	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—bone cancer	8.16e-05	0.000929	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—bone cancer	8.15e-05	0.000927	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—bone cancer	8.14e-05	0.000926	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—bone cancer	8.09e-05	0.000921	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—bone cancer	8.06e-05	0.000917	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—bone cancer	8.03e-05	0.000914	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—bone cancer	8.01e-05	0.000912	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—bone cancer	7.95e-05	0.000904	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—bone cancer	7.93e-05	0.000903	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—bone cancer	7.93e-05	0.000903	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methotrexate—bone cancer	7.87e-05	0.000896	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—bone cancer	7.83e-05	0.000891	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—bone cancer	7.79e-05	0.000887	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—bone cancer	7.77e-05	0.000884	CcSEcCtD
Indomethacin—Constipation—Epirubicin—bone cancer	7.7e-05	0.000877	CcSEcCtD
Indomethacin—Pain—Epirubicin—bone cancer	7.7e-05	0.000877	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—bone cancer	7.65e-05	0.000871	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—bone cancer	7.61e-05	0.000866	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—bone cancer	7.61e-05	0.000866	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—bone cancer	7.54e-05	0.000858	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—bone cancer	7.49e-05	0.000852	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—bone cancer	7.43e-05	0.000846	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—bone cancer	7.42e-05	0.000845	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—bone cancer	7.41e-05	0.000844	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—bone cancer	7.37e-05	0.000839	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—bone cancer	7.34e-05	0.000835	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—bone cancer	7.25e-05	0.000825	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—bone cancer	7.19e-05	0.000818	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—bone cancer	7.16e-05	0.000815	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—bone cancer	7.13e-05	0.000811	CcSEcCtD
Indomethacin—Pain—Doxorubicin—bone cancer	7.13e-05	0.000811	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—bone cancer	7.12e-05	0.000811	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—bone cancer	7.12e-05	0.000811	CcSEcCtD
Indomethacin—Hypersensitivity—Methotrexate—bone cancer	7.09e-05	0.000807	CcSEcCtD
Indomethacin—Asthenia—Methotrexate—bone cancer	6.91e-05	0.000786	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—bone cancer	6.87e-05	0.000782	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—bone cancer	6.82e-05	0.000776	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—bone cancer	6.81e-05	0.000775	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—bone cancer	6.64e-05	0.000756	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—bone cancer	6.62e-05	0.000754	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—bone cancer	6.59e-05	0.00075	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—bone cancer	6.59e-05	0.00075	CcSEcCtD
Indomethacin—Diarrhoea—Methotrexate—bone cancer	6.59e-05	0.00075	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—bone cancer	6.46e-05	0.000736	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—bone cancer	6.37e-05	0.000726	CcSEcCtD
Indomethacin—Dizziness—Methotrexate—bone cancer	6.37e-05	0.000725	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—bone cancer	6.16e-05	0.000702	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—bone cancer	6.14e-05	0.000699	CcSEcCtD
Indomethacin—Vomiting—Methotrexate—bone cancer	6.12e-05	0.000697	CcSEcCtD
Indomethacin—Rash—Methotrexate—bone cancer	6.07e-05	0.000691	CcSEcCtD
Indomethacin—Dermatitis—Methotrexate—bone cancer	6.06e-05	0.00069	CcSEcCtD
Indomethacin—Headache—Methotrexate—bone cancer	6.03e-05	0.000686	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—bone cancer	5.98e-05	0.000681	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—bone cancer	5.96e-05	0.000678	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—bone cancer	5.9e-05	0.000671	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—bone cancer	5.73e-05	0.000652	CcSEcCtD
Indomethacin—Nausea—Methotrexate—bone cancer	5.72e-05	0.000651	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—bone cancer	5.7e-05	0.000649	CcSEcCtD
Indomethacin—Rash—Epirubicin—bone cancer	5.68e-05	0.000647	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—bone cancer	5.68e-05	0.000646	CcSEcCtD
Indomethacin—Headache—Epirubicin—bone cancer	5.64e-05	0.000642	CcSEcCtD
Indomethacin—ABCB1—bone marrow—bone cancer	5.63e-05	0.00307	CbGeAlD
Indomethacin—ABCB1—spinal cord—bone cancer	5.61e-05	0.00306	CbGeAlD
Indomethacin—Dizziness—Doxorubicin—bone cancer	5.51e-05	0.000627	CcSEcCtD
Indomethacin—Nausea—Epirubicin—bone cancer	5.35e-05	0.000609	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—bone cancer	5.3e-05	0.000603	CcSEcCtD
Indomethacin—Rash—Doxorubicin—bone cancer	5.26e-05	0.000598	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—bone cancer	5.25e-05	0.000598	CcSEcCtD
Indomethacin—Headache—Doxorubicin—bone cancer	5.22e-05	0.000594	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—bone cancer	4.95e-05	0.000564	CcSEcCtD
Indomethacin—PLA2G2A—Metabolism—CYP3A4—bone cancer	3.45e-05	0.000411	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IGF1R—bone cancer	3.44e-05	0.00041	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.43e-05	0.000409	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—GNA11—bone cancer	3.42e-05	0.000408	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—CDK4—bone cancer	3.41e-05	0.000406	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—MET—bone cancer	3.41e-05	0.000406	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—SMO—bone cancer	3.4e-05	0.000405	CbGpPWpGaD
Indomethacin—CYP2C9—Biological oxidations—CYP3A4—bone cancer	3.38e-05	0.000402	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	3.37e-05	0.000402	CbGpPWpGaD
Indomethacin—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	3.33e-05	0.000397	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	3.32e-05	0.000396	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—JUN—bone cancer	3.3e-05	0.000393	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—GRM4—bone cancer	3.29e-05	0.000392	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RGS1—bone cancer	3.29e-05	0.000392	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	3.28e-05	0.000391	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—GNA11—bone cancer	3.24e-05	0.000386	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—JUN—bone cancer	3.23e-05	0.000385	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—ENO2—bone cancer	3.21e-05	0.000383	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NT5C3A—bone cancer	3.19e-05	0.00038	CbGpPWpGaD
Indomethacin—CYP2C19—Biological oxidations—GSTP1—bone cancer	3.17e-05	0.000377	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.16e-05	0.000377	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	3.12e-05	0.000372	CbGpPWpGaD
Indomethacin—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	3.12e-05	0.000372	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—GNA11—bone cancer	3.11e-05	0.00037	CbGpPWpGaD
Indomethacin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	3.11e-05	0.00037	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—IL3—bone cancer	3.1e-05	0.00037	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—EZH2—bone cancer	3.09e-05	0.000368	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NDUFA12—bone cancer	3.06e-05	0.000364	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—TP53—bone cancer	2.98e-05	0.000355	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—DHFR—bone cancer	2.98e-05	0.000355	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—GSTP1—bone cancer	2.95e-05	0.000352	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—CYP3A4—bone cancer	2.93e-05	0.00035	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.92e-05	0.000348	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.91e-05	0.000346	CbGpPWpGaD
Indomethacin—CYP2C9—Biological oxidations—GSTP1—bone cancer	2.89e-05	0.000344	CbGpPWpGaD
Indomethacin—CXCL8—Cellular Senescence—TP53—bone cancer	2.88e-05	0.000344	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—GRM1—bone cancer	2.85e-05	0.00034	CbGpPWpGaD
Indomethacin—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	2.85e-05	0.000339	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—MMP2—bone cancer	2.84e-05	0.000339	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL3—bone cancer	2.82e-05	0.000336	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—GNA11—bone cancer	2.78e-05	0.000332	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—ENO2—bone cancer	2.78e-05	0.000332	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	2.78e-05	0.000331	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.77e-05	0.00033	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.73e-05	0.000325	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—MMP9—bone cancer	2.68e-05	0.000319	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—DHFR—bone cancer	2.58e-05	0.000308	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TGFBR2—bone cancer	2.58e-05	0.000307	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—EIF2S1—bone cancer	2.55e-05	0.000304	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SMO—bone cancer	2.54e-05	0.000303	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NT5C3A—bone cancer	2.53e-05	0.000302	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—CYP3A4—bone cancer	2.52e-05	0.000301	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—PLAU—bone cancer	2.52e-05	0.000301	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.51e-05	0.000299	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—GSTP1—bone cancer	2.51e-05	0.000299	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—KIT—bone cancer	2.49e-05	0.000297	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NDUFA12—bone cancer	2.47e-05	0.000295	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MET—bone cancer	2.44e-05	0.000291	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—CDK4—bone cancer	2.44e-05	0.000291	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—GNA11—bone cancer	2.41e-05	0.000288	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.39e-05	0.000285	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—BRAF—bone cancer	2.34e-05	0.000279	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TP53—bone cancer	2.34e-05	0.000279	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—GNA11—bone cancer	2.33e-05	0.000277	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—EGFR—bone cancer	2.27e-05	0.000271	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NDUFA12—bone cancer	2.22e-05	0.000265	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—EZH2—bone cancer	2.21e-05	0.000264	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—CYP3A4—bone cancer	2.19e-05	0.000261	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—TP53—bone cancer	2.18e-05	0.00026	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.18e-05	0.000259	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NDUFA12—bone cancer	2.17e-05	0.000258	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—EGFR—bone cancer	2.16e-05	0.000258	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ATF1—bone cancer	2.16e-05	0.000258	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—GSTP1—bone cancer	2.16e-05	0.000257	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.15e-05	0.000257	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—MMP9—bone cancer	2.14e-05	0.000255	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—TP53—bone cancer	2.13e-05	0.000254	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL3—bone cancer	2.11e-05	0.000251	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ENO2—bone cancer	2.11e-05	0.000251	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ENO2—bone cancer	2.11e-05	0.000251	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SPARC—bone cancer	2.1e-05	0.00025	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.06e-05	0.000246	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NT5C3A—bone cancer	2.05e-05	0.000244	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MMP2—bone cancer	2.04e-05	0.000243	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NDUFA12—bone cancer	2.02e-05	0.000241	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SMO—bone cancer	2.01e-05	0.000239	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—MMP2—bone cancer	2e-05	0.000238	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ENO2—bone cancer	1.99e-05	0.000238	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ENO2—bone cancer	1.97e-05	0.000235	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MDM2—bone cancer	1.96e-05	0.000234	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—DHFR—bone cancer	1.96e-05	0.000233	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—DHFR—bone cancer	1.96e-05	0.000233	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—GNA11—bone cancer	1.92e-05	0.000229	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.87e-05	0.000223	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—GSTP1—bone cancer	1.87e-05	0.000223	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—DHFR—bone cancer	1.85e-05	0.000221	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NT5C3A—bone cancer	1.84e-05	0.000219	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ENO2—bone cancer	1.84e-05	0.000219	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—GNA11—bone cancer	1.84e-05	0.000219	CbGpPWpGaD
Indomethacin—ABCC1—Disease—DHFR—bone cancer	1.83e-05	0.000218	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—GNA11—bone cancer	1.83e-05	0.000218	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—GNA11—bone cancer	1.83e-05	0.000218	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TP53—bone cancer	1.82e-05	0.000217	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFBR2—bone cancer	1.8e-05	0.000215	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NT5C3A—bone cancer	1.79e-05	0.000214	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KIT—bone cancer	1.76e-05	0.00021	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL3—bone cancer	1.74e-05	0.000207	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GNA11—bone cancer	1.73e-05	0.000206	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—EGFR—bone cancer	1.73e-05	0.000206	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ENO2—bone cancer	1.71e-05	0.000204	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ENO2—bone cancer	1.71e-05	0.000204	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ATF1—bone cancer	1.71e-05	0.000203	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—JUN—bone cancer	1.71e-05	0.000203	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—DHFR—bone cancer	1.7e-05	0.000203	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IGF1R—bone cancer	1.7e-05	0.000202	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NT5C3A—bone cancer	1.68e-05	0.0002	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL3—bone cancer	1.66e-05	0.000198	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MMP9—bone cancer	1.66e-05	0.000198	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CYP3A4—bone cancer	1.66e-05	0.000198	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CYP3A4—bone cancer	1.66e-05	0.000198	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—BRAF—bone cancer	1.65e-05	0.000197	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ENO2—bone cancer	1.65e-05	0.000197	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.65e-05	0.000197	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GNA11—bone cancer	1.59e-05	0.00019	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—DHFR—bone cancer	1.59e-05	0.00019	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—DHFR—bone cancer	1.59e-05	0.00019	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ENO2—bone cancer	1.57e-05	0.000187	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CYP3A4—bone cancer	1.57e-05	0.000187	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.56e-05	0.000186	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—DHFR—bone cancer	1.53e-05	0.000183	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MMP9—bone cancer	1.53e-05	0.000183	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PTGS2—bone cancer	1.53e-05	0.000182	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.53e-05	0.000182	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GNA11—bone cancer	1.49e-05	0.000177	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GNA11—bone cancer	1.49e-05	0.000177	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.47e-05	0.000176	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.47e-05	0.000176	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—DHFR—bone cancer	1.46e-05	0.000174	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CYP3A4—bone cancer	1.44e-05	0.000172	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.44e-05	0.000171	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GNA11—bone cancer	1.43e-05	0.000171	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFBR2—bone cancer	1.42e-05	0.00017	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—GSTP1—bone cancer	1.42e-05	0.000169	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—GSTP1—bone cancer	1.42e-05	0.000169	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ENO2—bone cancer	1.4e-05	0.000167	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MDM2—bone cancer	1.38e-05	0.000165	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GNA11—bone cancer	1.36e-05	0.000162	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CYP3A4—bone cancer	1.35e-05	0.000161	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CYP3A4—bone cancer	1.35e-05	0.000161	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—EGFR—bone cancer	1.34e-05	0.00016	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GSTP1—bone cancer	1.34e-05	0.00016	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.34e-05	0.00016	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IGF1R—bone cancer	1.34e-05	0.00016	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTGS2—bone cancer	1.33e-05	0.000159	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.33e-05	0.000158	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFBR2—bone cancer	1.33e-05	0.000158	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ENO2—bone cancer	1.32e-05	0.000158	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PTGS2—bone cancer	1.3e-05	0.000155	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CYP3A4—bone cancer	1.3e-05	0.000155	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—DHFR—bone cancer	1.3e-05	0.000155	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.29e-05	0.000154	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—EGFR—bone cancer	1.24e-05	0.000148	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.24e-05	0.000147	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GSTP1—bone cancer	1.23e-05	0.000147	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CYP3A4—bone cancer	1.23e-05	0.000147	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KIT—bone cancer	1.23e-05	0.000147	CbGpPWpGaD
Indomethacin—PTGS2—Disease—DHFR—bone cancer	1.23e-05	0.000146	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.23e-05	0.000146	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GNA11—bone cancer	1.21e-05	0.000144	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—BRAF—bone cancer	1.16e-05	0.000138	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GSTP1—bone cancer	1.15e-05	0.000137	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GSTP1—bone cancer	1.15e-05	0.000137	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PLAU—bone cancer	1.14e-05	0.000136	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—bone cancer	1.13e-05	0.000134	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTGS2—bone cancer	1.12e-05	0.000133	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GSTP1—bone cancer	1.11e-05	0.000132	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ENO2—bone cancer	1.11e-05	0.000132	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CYP3A4—bone cancer	1.1e-05	0.000131	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.09e-05	0.00013	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GSTP1—bone cancer	1.06e-05	0.000126	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.04e-05	0.000124	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—DHFR—bone cancer	1.03e-05	0.000123	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—bone cancer	1.01e-05	0.000121	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KIT—bone cancer	9.71e-06	0.000116	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MDM2—bone cancer	9.7e-06	0.000116	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—bone cancer	9.69e-06	0.000116	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GNA11—bone cancer	9.62e-06	0.000115	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EGFR—bone cancer	9.46e-06	0.000113	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GSTP1—bone cancer	9.39e-06	0.000112	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—BRAF—bone cancer	9.13e-06	0.000109	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KIT—bone cancer	9.05e-06	0.000108	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ENO2—bone cancer	8.97e-06	0.000107	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFBR2—bone cancer	8.9e-06	0.000106	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—EGFR—bone cancer	8.85e-06	0.000105	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	8.76e-06	0.000104	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP3A4—bone cancer	8.72e-06	0.000104	CbGpPWpGaD
Indomethacin—ABCC1—Disease—BRAF—bone cancer	8.51e-06	0.000101	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—JUN—bone cancer	8.43e-06	0.0001	CbGpPWpGaD
Indomethacin—ALB—Metabolism—DHFR—bone cancer	8.32e-06	9.92e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MMP9—bone cancer	8.2e-06	9.77e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ENO2—bone cancer	8.05e-06	9.6e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ENO2—bone cancer	7.86e-06	9.37e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GNA11—bone cancer	7.78e-06	9.27e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MDM2—bone cancer	7.65e-06	9.12e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—DHFR—bone cancer	7.47e-06	8.91e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTP1—bone cancer	7.46e-06	8.89e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—bone cancer	7.35e-06	8.76e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—bone cancer	7.35e-06	8.76e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ENO2—bone cancer	7.34e-06	8.76e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—DHFR—bone cancer	7.29e-06	8.69e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MDM2—bone cancer	7.13e-06	8.5e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP3A4—bone cancer	7.05e-06	8.41e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.02e-06	8.37e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GNA11—bone cancer	6.98e-06	8.33e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—bone cancer	6.95e-06	8.28e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—bone cancer	6.87e-06	8.19e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GNA11—bone cancer	6.82e-06	8.13e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—DHFR—bone cancer	6.81e-06	8.12e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—JUN—bone cancer	6.65e-06	7.92e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—bone cancer	6.63e-06	7.9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—bone cancer	6.47e-06	7.71e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—bone cancer	6.4e-06	7.62e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GNA11—bone cancer	6.37e-06	7.59e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP3A4—bone cancer	6.33e-06	7.55e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.3e-06	7.51e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP3A4—bone cancer	6.18e-06	7.37e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KIT—bone cancer	6.07e-06	7.24e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTP1—bone cancer	6.03e-06	7.19e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—bone cancer	5.97e-06	7.12e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—bone cancer	5.97e-06	7.12e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP3A4—bone cancer	5.77e-06	6.88e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—bone cancer	5.76e-06	6.86e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.74e-06	6.85e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BRAF—bone cancer	5.71e-06	6.81e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—bone cancer	5.56e-06	6.63e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—bone cancer	5.47e-06	6.52e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTP1—bone cancer	5.41e-06	6.46e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTP1—bone cancer	5.29e-06	6.3e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—bone cancer	5.23e-06	6.23e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTP1—bone cancer	4.94e-06	5.89e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—bone cancer	4.87e-06	5.81e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—bone cancer	4.87e-06	5.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MDM2—bone cancer	4.78e-06	5.7e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—bone cancer	4.59e-06	5.47e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—bone cancer	4.39e-06	5.23e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—bone cancer	3.27e-06	3.9e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—bone cancer	3.13e-06	3.73e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—bone cancer	2.81e-06	3.34e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—bone cancer	2.74e-06	3.26e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—bone cancer	2.56e-06	3.05e-05	CbGpPWpGaD
